Astellas

Amgen wades deeper into Asia with full control of an Astellas Japanese JV
Fierce Pharma
Thu, 01/23/20 - 12:12 pm
Amgen
Astellas
Japan
BeiGene
China
Adaptimmune and Astellas to Co-Develop Allogenic CAR-T and TCR T-Cell Therapies
BioSpace
Tue, 01/14/20 - 10:46 am
Adaptimmune
SPEAR-T
Astellas
CAR-T
cell therapy
drug development
A big finish confirms 2019 as a takeover year to remember
EP Vantage
Thu, 01/9/20 - 10:49 am
M&A
AbbVie
Allergan
Astellas
Bristol-Myers Squibb
Eli Lilly
Merck
Novartis
Pfizer
Sanofi
Corporate and regulatory developments over the Christmas period
EP Vantage
Thu, 01/2/20 - 11:39 pm
Astellas
M&A
Qiagen
AstraZeneca
Bausch Health
BeiGene
Celyad
Immunomedics
Merck
Merck KGaA
Ono Pharmaceutical
Pfizer
Pharming
Xyphos Biosciences
Astellas ramps up M&A, buys U.S. biotech Xyphos for as much as $665 million
Reuters
Mon, 12/30/19 - 10:59 am
Astellas
Xyphos Biosciences
M&A
Audentes Therapeutics
Seattle Genetics, Astellas snag quick FDA approval for bladder cancer-fighter Padcev
Fierce Pharma
Wed, 12/18/19 - 11:57 pm
Seattle Genetics
Astellas
FDA
Padcev
metastatic bladder cancer
Pfizer, Astellas' Xtandi matches J&J's rival Erleada with new prostate cancer nod
Fierce Pharma
Mon, 12/16/19 - 10:37 pm
Pfizer
Astellas
Xtandi
prostate cancer
JNJ
Erleada
FDA
Deserted by Astellas and Merck, little Correvio still can't win over FDA panel concerned with its AFib drug's safety
Endpoints
Wed, 12/11/19 - 10:29 am
Correvio
Astellas
Merck
clinical trials
atrial fibrillation
Vernakalant
Brinavess
Gene Therapy M&A Appetite Provides Lift After Audentes Deal
Yahoo/Bloomberg
Wed, 12/4/19 - 10:02 am
gene therapy
Astellas
Audentes Therapeutics
M&A
Novartis
Medicines Company
Japan's Astellas to buy Audentes for $3 billion in gene therapy push
Reuters
Mon, 12/2/19 - 11:58 pm
Astellas
M&A
gene therapy
Audentes Therapeutics
Top 10 pharma settlements since 2018
Fierce Pharma
Tue, 11/19/19 - 10:27 am
settlements
Reckitt Benckiser
JNJ
Bayer
Allergan
Actelion
Purdue Pharma
Teva Pharmaceutical
Endo
Teikoku
Insys
Pfizer
GSK
Astellas
Amgen
Pandion, Astellas sign $900m deal for pancreas-targeted immunomodulators
Pharmaceutical Business Review
Thu, 10/31/19 - 11:03 am
Astellas
Pandion Therapeutics
immunomodulators
autoimmune disease
Pancreas
Seattle Genetics makes case it can be more than Adcetris
Biopharma Dive
Mon, 09/30/19 - 12:03 pm
Seattle Genetics
Adcetris
clinical trials
ESMO
enfortumab vedotin
Astellas
tucatinib
ESMO: Astellas, Seattle Genetics' Keytruda combo shrinks 71% of bladder cancers
Fierce Biotech
Sat, 09/28/19 - 04:36 pm
Seattle Genetics
Astellas
enfortumab vedotin
bladder cancer
ESMO
urothelial cancer
Astellas maintains lead over Daiichi Sankyo with CHMP okay for Xospata
Pharmaforum
Sun, 09/22/19 - 11:02 pm
Astellas
AML
Xospata
Europe
Daiichi Sankyo
Astellas' AML drug wins over CHMP — strengthening lead on Daiichi Sankyo
Endpoints
Fri, 09/20/19 - 10:40 pm
Astellas
FDA
gilteritinib
Europe
AML
Daiichi Sankyo
Astellas hires first chief patient exec to make 'centricity' more than a buzzword
Fierce Pharma
Mon, 09/9/19 - 10:03 am
Astellas
patients
patient centricity
Sanofi
drug discovery
Pfizer, Astellas rocket toward broader Xtandi use with FDA 'priority' tag
Fierce Pharma
Thu, 08/22/19 - 11:56 am
Pfizer
Astellas
Xtandi
prostate cancer
FDA
priority review
Astellas tests gamification ideas with Japanese universities
Pharmaforum
Thu, 08/15/19 - 10:45 am
Astellas
Japan
gamification
Astellas pushes non-hormonal menopause drug into phase 3
Pharmaforum
Wed, 08/7/19 - 11:48 pm
Astellas
menopause
clinical trials
fezolinetant

Pages